|
| Name : |
Ifa |
| Surname : |
Etesami |
| From : |
Monday, September 16, 2024 |
| To : |
Friday, June 7, 2024 |
| Position : |
Associate professor |
| School/Research center : |
School of Medicine |
| subject : |
clinical fellowship in cutaneous lymphoma |
| Venue : |
Helios Klinikum Krefeld |
| Sabbatical Leave Period : |
3 months |
| Country : |
Germany |
| 1.Brief summary of Leave : |
In this clinical fellowship, I had the chance to visit many dermatooncology patient in a specialized center under the supervision of a dermato-oncologist and learn about the latest updates in this field. |
| 2.List the objectives of your sabbatical leave as listed in your proposal and indicate how completely they were met : |
I learned about the latest treatment modalities of late stage Mycosis Fungoides and Sezary syndrome including Extracorporeal Photophoresis (ECP), Total Skin Electron Beam Radiotherapy (TSEB) and Immunetherapies. I learned about the new immune therapies for Mycosis Fungoides such as mogamulizumab, and Brentuximab (the dosages, side effects, efficacy) I had the chance to observe the ultra-hypofractionated low-dose TSEB that is performed in Helios Klinikum for tumoral stage MF patients. Also I observed Sentinel Lymph node dissections performed by dermatologist at Helios Klinikum Krefeld for Melanoma patients. During my 3 months stay, I had the chance to follow the MF patients through their treatment protocol and observe their response to treatments such as extracorporeal photophoresis, Total skin radiotherapy. During my near 3 months stay I had the chance to follow the patients from their first diagnosis of melanoma through the surgery and sentinel lymph node biopsy, staging process and adjuvent immune therapies. |
| 3.Acheivements(Publications,research,et.al.) : |
one mutual publication "Vahabi SM, Bahramian S, Esmaeili F, Danaei B, Kalantari Y, Fazeli P, Sadeghi S, Hajizadeh N, Assaf C, Etesami I. JAK Inhibitors in Cutaneous T-Cell Lymphoma: Friend or Foe? A Systematic Review of the Published Literature. Cancers (Basel). 2024 Feb 21;16(5):861. doi: 10.3390/cancers16050861. PMID: 38473222; PMCID: PMC10930951." |
| 4.Assessment of Value of Sabbatical leave(benefits,faculty development,future professional activities,...) : |
The EADV clinical fellowship at Helios Klinikum Krefeld in cutaneous lymphoma under the supervision of Dr. Chalid Assaf was a unique experience that allowed me to understand the latest treatment options for patients with Advanced stages of cutaneous T-cell lymphoma. This opportunity not only broadened my understanding of dermato-oncology but also ignited a passion for this valuable field that I aim to integrate into my future medical practice in my home country. I am grateful for the knowledge and insights gained during this fellowship, which have paved the way for my continued growth and development as a healthcare professional |
| Department Head/Research Center Chair : |
Dr. Chalid Assaf |
| Any Related to Report File : |